MyMemory, World's Largest Translation Memory
Click to expand

Language pair: Click to swap content  Subject   
Ask Google

You searched for: portatore cronico di hbsag    [ Turn off colors ]

Human contributions

From professional translators, enterprises, web pages and freely available translation repositories.

Add a translation

Italian

English

Info

Portatore di carica

Current Carrier

Last Update: 2012-05-03
Usage Frequency: 1
Quality:
Reference: Wikipedia

portatore di carica

charge carrier

Last Update: 2011-11-17
Subject: Mathematics and Physics
Usage Frequency: 1
Quality:

portatore di protesi anca

hip prostheses

Last Update: 2013-10-24
Subject: General
Usage Frequency: 1
Quality:
Reference: Anonymous

Portatore sano

Asymptomatic carrier

Last Update: 2013-10-11
Usage Frequency: 1
Quality:
Reference: Wikipedia

Portatore sano

Genetic carrier

Last Update: 2013-11-18
Usage Frequency: 1
Quality:
Reference: Wikipedia

Sero-conversione HBsAg

HBsAg Sero-conversion

Last Update: 2008-03-04
Subject: Medical
Usage Frequency: 7
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.

Ospite portatore / Vettore

Reservoir/host

Last Update: 2012-12-01
Usage Frequency: 1
Quality:

Perdita HBsAg / sieroconversione
http://www.emea.europa.eu/

HBsAg loss/ seroconversion
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:

Infine, i documenti citati dal richiedente indicano che UMAN BIG è riuscito ad evitare che i neonati di madri infette da HBeAg diventassero portatori cronici dell' HBsAg.
http://www.emea.europa.eu/

Finally, the papers quoted by the Applicant indicate that UMAN BIG prevented newborns from HBeAg infected mothers from becoming chronic HBsAg carriers.
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:

I pazienti con epatopatia cronica o con infezione da HIV o portatori di epatite C non devono essere esclusi dalla vaccinazione contro epatite B.
http://www.emea.europa.eu/

Patients with chronic liver disease or with HIV infection or hepatitis C carriers should not be precluded from vaccination against hepatitis B.
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:

La vaccinazione contro l’ epatite B non deve essere esclusa in pazienti affetti da malattie croniche del fegato o con infezione da HIV o portatori di epatite C.
http://www.emea.europa.eu/

Patients with chronic liver disease or with HIV infection or hepatitis C carriers should not be precluded from vaccination against hepatitis B.
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 7
Quality:

In pazienti portatori cronici del virus dell’ epatite B sottoposti a trattamento con antagonisti del TNF Me
http://www.emea.europa.eu/

Reactivation of hepatitis B has occurred in patients receiving a TNF-antagonist including Trudexa, who are chronic carriers of this virus.
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:

In pazienti portatori cronici del virus dell’ epatite B sottoposti a trattamento con antagonisti del TNF incluso TRUDEXA, si è verificata una riattivazione dell’ epatite B.
http://www.emea.europa.eu/

Reactivation of hepatitis B has occurred in patients receiving a TNF-antagonist including Trudexa, who are chronic carriers of this virus.
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 3
Quality:

Cronica
http://www.emea.europa.eu/

Chronic
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:

Riattivazione di epatite B La riattivazione dell’ epatite B si è osservata in pazienti trattati con un TNF-antagonista, incluso il Remicade e che erano portatori cronici di questo virus.
http://www.emea.europa.eu/

7 Reactivation of hepatitis B has occurred in patients receiving a TNF-antagonist including Remicade, who are chronic carriers of this virus.
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:

In particolare, i portatori cronici asintomatici devono essere identificati e trattati prima della vaccinazione con sostanze che non compromettano la risposta immunitaria.
http://www.emea.europa.eu/

In particular, chronic asymptomatic carriers should be identified and treated before vaccination, with substances that do not compromise immunological responsiveness.
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 2
Quality:

nei pazienti con epatite cronica B (CHB) HBeAg positiva, il trattamento deve essere somministrato per almeno 3-6 mesi dopo che la sieroconversione HBeAg (scomparsa di HBeAg e HBV DNA con rilevazione di HBeAb) è stata confermata, per limitare il rischio di ricaduta virologica o fino alla sieroconversione HBsAg.
http://www.emea.europa.eu/

In patients with HBeAg positive chronic hepatitis B (CHB) treatment should be administered for at least 3-6 months after HBeAg seroconversion (HBeAg and HBV DNA loss with HBeAb detection) is confirmed, to limit the risk of virological relapse, or until HBsAg seroconversion.
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:

In pazienti portatori cronici del virus dell’ epatite B quando sottoposti a trattamento con antagonisti del TNF incluso Humira, si è verificata una riattivazione dell’ epatite B.
http://www.emea.europa.eu/

Reactivation of hepatitis B has occurred in patients who are chronic carriers of this virus when receiving a TNF-antagonist including Humira.
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:

E’ stata riportata riattivazione del virus dell’ Epatite B (HBV) in pazienti portatori cronici di questo virus che ricevono anti-TNF come Enbrel.
http://www.emea.europa.eu/

Reactivation of hepatitis B virus (HBV) in patients who are chronic carriers of this virus who are receiving TNF-antagonists including Enbrel has been reported.
http://www.emea.europa.eu/

Last Update: 2012-04-12
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:

portatore di tumore

tumor-bearing

Last Update: 2011-09-30
Subject: Medical
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.

Add a translation